KRAS; A Key Oncogenic Driver and Novel Investigational Target in NSCLC

Join the APP Consortium for the excellent webinar, KRAS; A Key Oncogenic Driver and Novel Investigational Target in NSCLC!

RSVP TODAY!

© 2021 FLASCO | Premium Website Design by The HDG

FLASCO